AUA 2020 – Clinically low-risk prostate cancer

Dr. Aaron Katz, MD, Chairman of Urology at NYU Winthrop Hospital and Professor of Urology NYU School of Medicine, discusses the Oncotype DX Genomic Prostate Score® (GPS™) test and how it is used by physicians and he covers the Abstract from the American Urological Association (AUA) 2020 meeting titled “A 17 -Gene RT RT-PCR Prostate Assay: Clinical Experience in 33,000 Patients with Clinically Low-Risk Prostate Cancer” 

Aaron E. Katz, MD, FACS, is currently the Chairman of Urology at NYU Winthrop Hospital and Professor of Urology NYU School of Medicine. Dr. Katz established and serves as the Program Director of Urology Residency Program at NYU Long Island School of Medicine and an attending physician at Winthrop Urology, a progressive Urology practice with offices in Garden City, Long Island, and the upper east side of Manhattan.

Liked it? Take a second to support healthprofessionalradio on Patreon!

0 Comments

Leave a Reply

You must be logged in to post a comment.